In cancer, ransforming growth factor β (TGF-β)and reticular activating system, (RAS) signaling have been shown to work together to activate “primed” enhancers that drive HAS2 expression, thereby promoting metastasis [23,36,37]. The gene discussed is HAS2; the disease is cancer.